View in EDS

Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes.

Saved in:
Bibliographic Details
Title: Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes.
Authors: Killedar A; Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia. anagha.killedar@sydney.edu.au., Howell M; Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia., Howard K; Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia., Norris S; Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia.
Source: PharmacoEconomics [Pharmacoeconomics] 2026 Mar; Vol. 44 (3), pp. 279-286. Date of Electronic Publication: 2025 Dec 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41335311
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Killedar+A%22">Killedar A</searchLink>; Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia. anagha.killedar@sydney.edu.au.<br /><searchLink fieldCode="AU" term="%22Howell+M%22">Howell M</searchLink>; Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia.<br /><searchLink fieldCode="AU" term="%22Howard+K%22">Howard K</searchLink>; Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia.<br /><searchLink fieldCode="AU" term="%22Norris+S%22">Norris S</searchLink>; Leeder Centre for Health Policy, Economics and Data, School of Public Health, Faculty of Medicine and Health, University of Sydney, Level 5, Moore College CG2, 1 King Street, Newtown, NSW, 2042, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2026 Mar; Vol. 44 (3), pp. 279-286. <i>Date of Electronic Publication: </i>2025 Dec 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41335311
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40273-025-01568-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 279
    Titles:
      – TitleFull: Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Killedar A
      – PersonEntity:
          Name:
            NameFull: Howell M
      – PersonEntity:
          Name:
            NameFull: Howard K
      – PersonEntity:
          Name:
            NameFull: Norris S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2027
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: PharmacoEconomics
              Type: main
ResultId 1